Klinicki Centar Kragujevac
About Klinicki Centar Kragujevac
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Klinicki Centar Kragujevac
During the past decade, Klinicki Centar Kragujevac conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-line Treatment of Ovarian Cancer
2006-01-01
2011-12-01
Completed
105
Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor
2007-09-01
Completed
73
Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients
2007-02-01
2022-01-01
Unknown status
2,017
Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors
2008-06-01
2012-01-01
Completed
41
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
2009-10-29
2014-07-09
Completed
361
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
2010-07-01
2020-12-31
Completed
408
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE)
2012-10-22
2016-04-28
Completed
208
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinicki Centar Kragujevac" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Immunic AG" with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "Aileron Therapeutics, Inc." with 1 trials sponsored and "Idorsia Pharmaceuticals Ltd."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinicki Centar Kragujevac"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Klinicki Centar Kragujevac
According to Clinical.Site data, the most researched conditions in "Klinicki Centar Kragujevac" are
"Acute Myocardial Infarction" (1 trials), "Esophagitis" (1 trials), "Moderate to Severe Ulcerative Colitis" (1 trials), "Multiple Sclerosis" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Klinicki Centar Kragujevac" in a lesser frequency.
Clinical Trials Intervention Types at Klinicki Centar Kragujevac
Most popular intervention types in "Klinicki Centar Kragujevac" are "Drug" (7 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "0 mg Induction ONLY" (1 trials), "150 mg Induction/Chronic" (1 trials), "450 mg Induction/Chronic" (1 trials) and "50 mg Induction/Chronic" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinicki Centar Kragujevac
The vast majority of trials in "Klinicki Centar Kragujevac" are
8 trials for "All" genders.
Clinical Trials Status at Klinicki Centar Kragujevac
Currently, there are NaN active trials in "Klinicki Centar Kragujevac".
undefined are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 1 completed trials in Klinicki Centar Kragujevac,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Klinicki Centar Kragujevac, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".